Share on StockTwits

Equities researchers at Societe Generale upped their target price on shares of Mead Johnson Nutrition CO (NYSE:MJN) from $94.00 to $100.00 in a research report issued on Monday, Analyst RN reports. Societe Generale’s price target indicates a potential upside of 13.79% from the stock’s previous close.

A number of other analysts have also recently weighed in on MJN. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Mead Johnson Nutrition CO in a research note on Tuesday, April 22nd. They now have a $92.00 price target on the stock, down previously from $93.00. Separately, analysts at JPMorgan Chase & Co. raised their price target on shares of Mead Johnson Nutrition CO from $89.00 to $92.00 in a research note on Monday, March 10th. They now have an “overweight” rating on the stock. Finally, analysts at Citigroup Inc. raised their price target on shares of Mead Johnson Nutrition CO from $95.00 to $104.00 in a research note on Friday, March 7th. They now have a “buy” rating on the stock. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $91.98.

Mead Johnson Nutrition CO (NYSE:MJN) traded up 0.90% on Monday, hitting $87.88. The stock had a trading volume of 1,496,702 shares. Mead Johnson Nutrition CO has a 52 week low of $66.80 and a 52 week high of $88.87. The stock has a 50-day moving average of $83.92 and a 200-day moving average of $82.1. The company has a market cap of $17.722 billion and a P/E ratio of 27.30.

Mead Johnson Nutrition CO (NYSE:MJN) last released its earnings data on Thursday, April 24th. The company reported $1.02 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.91 by $0.11. The company had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter in the prior year, the company posted $0.85 earnings per share. The company’s quarterly revenue was up 7.3% on a year-over-year basis. On average, analysts predict that Mead Johnson Nutrition CO will post $3.64 earnings per share for the current fiscal year.

In other Mead Johnson Nutrition CO news, Director Stephen Golsby unloaded 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 15th. The stock was sold at an average price of $83.25, for a total value of $832,500.00. Following the completion of the transaction, the director now directly owns 93,964 shares of the company’s stock, valued at approximately $7,822,503. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Mead Johnson Nutrition Company (NYSE:MJN) is a global pediatric nutrition company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.